← Back to all trials
Enrolling By Invitation
NCT04650568
Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction
Conditions: Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Rupture
Sex: All
Ages: 18 Years – 60 Years
Healthy volunteers: No
Phase: NA
Enrollment: 100
Sponsor: Rush University Medical Center
Location: Rush University Medical Center Chicago Illinois
Summary
This study will evaluate the efficacy of biologic augmentation of ACL reconstruction with bone marrow derived mesenchymal stem cells as measured by magnetic resonance imaging to detect graft healing and integration. Secondary endpoints will include validated patient reported outcome measures, as well as functional outcome using objective examination findings.
Eligibility Criteria
Inclusion Criteria:
* English-speaking patients
* 18-60 years of age with acute ACL injury (\
Source: ClinicalTrials.gov (NCT04650568). StuddyBuddy aggregates publicly available trial information.
